From: Association of invasion-promoting tenascin-C additional domains with breast cancers in young women
Clinicopathological feature | Â | Total TNC | TNC-AD1 | TNC-AD2 | |||
---|---|---|---|---|---|---|---|
 | n | Mean Ct (95% CI) | P | Mean Ct (95% CI) | P | Mean Ct (95% CI) | P |
Age | Â | Â | Â | Â | Â | Â | Â |
   ≤40 years | 47 | 23.5 (21.8 to 25.3) | 0.006 | 36.6 (35.4 to 37.7) | <0.001 | 37.7 (36.7 to 38.6) | 0.001 |
   >40 years | 87 | 26.5 (25.7 to 27.3) |  | 38.7 (38.1 to 39.3) |  | 39.1 (38.5 to 39.7) |  |
Tumour type | Â | Â | Â | Â | Â | Â | Â |
   IDC | 109 | 25.4 (24.4 to 26.4) | 0.554 | 37.8 (37.2 to 38.4) | 0.079 | 38.7 (38.2 to 39.2) | 0.760 |
   ILC | 25 | 25.6 (24.7 to 26.5) |  | 38.6 (37.1 to 40.0) |  | 38.3 (36.5 to 39.9) |  |
Grade | Â | Â | Â | Â | Â | Â | Â |
   I | 14 | 27.6 (25.9 to 29.4) | 0.109 | 39.1 (37.9 to 40.3) | 0.017 | 39.8 (39.3 to 40.2) | 0.066 |
   II | 63 | 25.7 (24.6 to 26.7) |  | 38.3 (37.4 to 39.1) |  | 38.7 (37.9 to 39.5) |  |
   III | 57 | 24.7 (23.2 to 26.1) |  | 37.3 (36.4 to 38.2) |  | 38.2 (37.4 to 39.0) |  |
Lymph node | Â | Â | Â | Â | Â | Â | Â |
   Positive | 63 | 25.4 (24.2 to 26.6) | 0.802 | 37.9 (37.2 to 38.8) | 0.978 | 38.8 (38.2 to 39.4) | 0.900 |
   Negative | 68 | 25.5 (24.4 to 26.7) |  | 37.9 (37.1 to 38.8) |  | 38.5 (37.7 to 39.3) |  |
   Not known | 3 |  |  |  |  |  |  |
Oestrogen receptor | Â | Â | Â | Â | Â | Â | Â |
   Positive | 89 | 25.6 (24.6 to 26.5) | 0.413 | 38.2 (37.6 to 38.9) | 0.011 | 38.7 (38.1 to 39.3) | 0.316 |
   Negative | 31 | 24.1 (22.2 to 26.1) |  | 36.7 (35.3 to 38.0) |  | 38.1 (36.9 to 39.3) |  |
   Not known | 14 |  |  |  |  |  |  |
Progesterone receptor | Â | Â | Â | Â | Â | Â | |
   Positive | 79 | 25.4 (24.5 to 26.4) | 0.431 | 37.9 (37.2 to 38.4) | 0.441 | 38.8 (38.2 to 39.3) | 0.641 |
   Negative | 36 | 24.5 (22.6 to 26.4) |  | 37.6 (36.4 to 38.7) |  | 38.1 (36.8 to 39.5) |  |
   Not known | 19 |  |  |  |  |  |  |
Her-2 | Â | Â | Â | Â | Â | Â | Â |
   Positive | 17 | 23.3 (20.5 to 26.2) | 0.232 | 37.6 (35.9 to 39.3) | 0.639 | 38.2 (36.6 to 39.8) | 0.452 |
   Negative | 81 | 25.1 (24.2 to 26.1) |  | 37.8 (37.0 to 38.6) |  | 38.7 (38.0 to 39.4) |  |
   Not known | 36 |  |  |  |  |  |  |
Basal 1 | Â | Â | Â | Â | Â | Â | Â |
   Positive | 23 | 24.3 (22.2 to 26.4) | 0.605 | 36.9 (35.3 to 38.6) | 0.170 | 38.4 (37.2 to 39.7) | 0.746 |
   Negative | 109 | 25.4 (24.5 to 26.3) |  | 38.0 (37.4 to 38.7) |  | 38.6 (37.9 to 39.1) |  |
   Not known | 2 |  |  |  |  |  |  |
Basal 2 | Â | Â | Â | Â | Â | Â | Â |
   Positive | 22 | 25.8 (23.1 to 28.4) | 0.103 | 37.6 (35.9 to 39.4) | 0.960 | 38.5 (37.3 to 39.6) | 1.000 |
   Negative | 51 | 23.2 (21.4 to 25.0) |  | 37.6 (36.6 to 38.7) |  | 38.5 (37.7 to 39.3) |  |
   Not known | 61 |  |  |  |  |  |  |